<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.healthnewspapers.com/science/ven-a-qui-venetoclax-quizartinib-aml</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Adding quizartinib to venetoclax drove AML remissions in an early-phase trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/risovalisib-pik3ca-ovarian-clear-cell-carcinoma</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>A PI3K inhibitor shrank tumours in a third of women with a rare ovarian cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/dirozalkib-crizotinib-alk-nsclc-diamond-2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>New ALK inhibitor more than doubled progression-free time versus crizotinib in NSCLC</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-immunohistochemistry-companion-diagnostics-reclassification</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>FDA proposes easing the approval path for cancer companion-diagnostic IHC tests</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-external-mechanical-stimulator-congestion-classification</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>FDA creates a device class for sinus-vibration stimulators that relieve congestion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/nutrition/omega-3-supplementation-blood-pressure-inflammation-pilot</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Omega-3 capsules moved blood pressure and inflammation markers in a small pilot</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/intensive-blood-pressure-cognition-brain-bproad-diabetes</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Intensive blood-pressure control did not cut dementia risk in a diabetes trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/onchocerciasis-maridi-dam-south-sudan-ov16-serosurvey</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>River blindness is still spreading near South Sudan&apos;s Maridi Dam, child serosurveys show</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/mers-cov-qatar-camel-workers-don626</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Qatar reports two MERS cases in camel workers, its first since 2022</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/american-samoa-dengue-outbreak-2025-2026-mmwr</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>American Samoa logged 1,048 dengue cases and no deaths in a 14-month outbreak</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/family-health/caffeine-neonatal-acute-kidney-injury-asphyxia-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>A single dose of caffeine at birth did not prevent kidney injury after asphyxia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/surmount-adolescents-tirzepatide-obesity</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Tirzepatide cut BMI by about 18% in adolescents with obesity in a phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/soul-oral-semaglutide-total-cardiovascular-events</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Oral semaglutide cut total heart events, not just first ones, in a diabetes trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/multibic-ckrt-replacement-solution-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>FDA approves Multibic, a mixed-electrolyte solution for continuous kidney therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/fragile-off-pump-on-pump-cabg-frail</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16</news:publication_date>
      <news:title>Off-pump and on-pump bypass surgery had similar outcomes in frail patients</news:title>
    </news:news>
  </url>
</urlset>